T, Z., J, K., N, Z., G, A., AT, B., DJ, S., . . . C, G. (2026). The Cancer Immunotherapy Thromboembolism Assessment: A Novel Score for Predicting Thromboembolic Events in Melanoma Patients Treated With Immune Checkpoint Inhibition. International journal of cancer. https://doi.org/10.1002/ijc.70523
Chicago Style (17th ed.) CitationT, Zell, et al. "The Cancer Immunotherapy Thromboembolism Assessment: A Novel Score for Predicting Thromboembolic Events in Melanoma Patients Treated With Immune Checkpoint Inhibition." International Journal of Cancer 2026. https://doi.org/10.1002/ijc.70523.
MLA (9th ed.) CitationT, Zell, et al. "The Cancer Immunotherapy Thromboembolism Assessment: A Novel Score for Predicting Thromboembolic Events in Melanoma Patients Treated With Immune Checkpoint Inhibition." International Journal of Cancer, 2026, https://doi.org/10.1002/ijc.70523.